News

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Author(s):

Pharmaceutical Technology Editors

Chesapeake to relocate and expand, AVI BioPharma appoints CEO, More...

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 19th 2025

Telstar to Showcase Integrated GMP Services at Farmaforum

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 19th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
White pills on blue background | Image Credit: © neirfy - © neirfy - stock.adobe.com
August 19th 2025

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 19th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
AbbVie’s facility in Silicon Valley, South San Francisco, California, USA - June 7, 2023. AbbVie Inc. is an American pharmaceutical company. | Image Credit: © JHVEPhoto - stock.adobe.com
August 19th 2025

AbbVie to Invest $195 Million in US API Manufacturing

Patrick Lavery
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 19th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery